Trinity Capital Inc. 7.875% Notes due 2029

NASDAQ:TRINZ

Asset Management

Financial Services
$25.23 -0.10%

-$0.02 today

Market cap
$1.12B
Beta
0.05
P/E (TTM)
9.1
EPS (TTM)
$1.84
Dividend yield
12.20%
52W Low $24.91High $25.66

Volume 0.00M

Average 0.01M

TRINZ Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Trinity Capital Inc. 7.875% Notes due 2029NASDAQ: TRINZ

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How TRINZ compares with its peers on the latest reported figures

  • TRINZ's LTM Mar 2026 research & development of $0 is the highest of the 8 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for TRINZ, versus a peer median of 0.0%.
TRINZ Competitors Peer median
Research & Development for TRINZ and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TRINZTrinity Capital Inc. 7.875% Notes due 2029LTM Mar 2026$0 ——0.0%
CSWCCapital Southwest CorporationLTM Mar 2026$0 ——0.0%
HQHAbrdn Healthcare InvestorsFY2025$0 ——0.0%
HTFCHorizon Technology Finance CorpLTM Mar 2026$0 ——0.0%
GSBDGoldman Sachs BDC, Inc.LTM Mar 2026$0 ——0.0%
MFICMidCap Financial Investment CorporationLTM Mar 2026$0 ——0.0%
NMFCNew Mountain Finance CorporationLTM Mar 2026$0 ——0.0%
HRZNHorizon Technology Finance CorporationLTM Mar 2026$0 ——0.0%
Peer median (excluding TRINZ) $0——0.0%

Competitors are the stored peer set for TRINZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue94.9M178.35M153.78M226.73M232.25M
Cost of Revenue00043.52M0
Gross Profit94.9M178.35M153.78M183.21M232.25M
Gross Margin100.0%100.0%100.0%80.8%100.0%
Research & Development00000
Selling, General & Admin00014.18M0
Operating Expenses(20.39M)(34.15M)(44.3M)14.18M16.09M
Depreciation & Amortization0174.58M32.6M00
EBITDA152.71M116.31M153.78M177.54M216.17M
EBITDA Margin160.9%65.2%100.0%78.3%93.1%
Operating Income152.71M3.77M121.19M169.04M216.17M
Operating Margin160.9%2.1%78.8%74.6%93.1%
Interest Income0000293.65M
Interest Expense000080.57M
Other Income / Expenses(20.39M)(34.15M)(44.3M)(53.44M)(80.57M)
Income Before Tax132.32M3.77M76.89M115.6M135.6M
Pre-Tax Margin139.4%2.1%50.0%51.0%58.4%
Income Tax Expense03.77M000
Net Income132.32M(30.38M)76.89M115.6M135.6M
Net Margin139.4%-17.0%50.0%51.0%58.4%
EPS (Basic)4.86(0.96)1.982.191.96
EPS (Diluted)4.86(0.96)1.802.101.96
Weighted Avg Shares27.23M31.67M38.91M52.71M69.29M
Weighted Avg Shares (Diluted)27.23M31.67M42.71M56.73M69.29M

Trinity Capital Inc. 7.875% Notes due 2029

NASDAQ:TRINZ

Intrinsic Alpha fair value

Locked

Current Price

$25.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.